Duration of gonadotropin-releasing hormone antagonist administration does not affect the outcome of subsequent frozen-thawed cycles
- 29 February 2004
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 81 (2) , 473-475
- https://doi.org/10.1016/j.fertnstert.2003.08.009
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Outcome for donors and recipients in two egg-sharing policiesFertility and Sterility, 2003
- Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-upFertility and Sterility, 2002
- GnRH antagonist in assisted reproduction: a Cochrane reviewHuman Reproduction, 2002
- Comparison of cryopreservation outcome with gonadotropin-releasing hormone agonists or antagonists in the collecting cycleFertility and Sterility, 2002
- Frozen-thawed embryo transfer: influence of clinical factors on implantation rate and risk of multiple conception.Human Reproduction, 2001
- Comment on the debate article: Embryo implantation: the Rubicon for GnRH antagonistsHuman Reproduction, 2001
- Embryo implantation and GnRH antagonistsHuman Reproduction, 2001
- Embryo implantation and GnRH antagonistsHuman Reproduction, 2000
- Embryo implantation and GnRH antagonistsHuman Reproduction, 2000
- High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze–thaw cyclesHuman Reproduction, 1999